CD44/HA signaling mediates acquired resistance to a PI3K alpha inhibitor

Yang, CX; Sheng, YM; Shi, XX; Liu, YW; He, YQ; Du, Y; Zhang, GL; Gao, F

Gao, F (corresponding author), Shanghai Jiao Tong Univ, Dept Mol Biol Lab, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China.; Gao, F (corresponding author), Shanghai Jiao Tong Univ, Dept Clin Lab, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China.

CELL DEATH & DISEASE, 2020; 11 (10):

Abstract

Most luminal breast carcinomas (BrCas) bearing PIK3CA mutations initially respond to phosphoinositide-3-kinase (PI3K)-alpha inhibitors, but many event......

Full Text Link